Binimetinib/encorafenibSparkling scotomas and palmoplantar hyperkeratosis: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1936卷 / 1期

关键词：

D O I：

10.1007/s40278-022-29319-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：122 / 122

相关论文

共 50 条

[31] RabeprazoleOesophageal hyperkeratosis?: case report
Reactions Weekly, 2013, 1443 (1) : 33 - 33
[32] Binimetinib/trametinibVarious toxicities: case report
Reactions Weekly, 2021, 1838 (1) : 111 - 111
[33] Binimetinib/encorafenibSeroretinal detachment: case report
Reactions Weekly, 2023, 1962 (1) : 99 - 99
[34] Binimetinib/encorafenibCollagenous colitis: case report
Reactions Weekly, 2025, 2056 (1) : 101 - 101
[35] Binimetinib/encorafenibTubulointerstitial nephritis: case report
Reactions Weekly, 2023, 1938 (1) : 325 - 325
[36] Binimetinib/ipilimumabVarious toxicities: case report
Reactions Weekly, 2018, 1691 (1) : 67 - 67
[37] VenlafaxineFirst report of keratoderma and hyperkeratosis: case report
Reactions Weekly, 2006, 1110 (1) : 18 - 18
[38] PALMOPLANTAR HYPERKERATOSIS (TYLOSIS) ASSOCIATED WITH A GASTRIC ADENOCARCINOMA
VOTION, V
MINEUR, P
MIRGAUX, M
AUPAIX, M
DERMATOLOGICA, 1982, 165 (06): : 660 - 663
[39] Binimetinib/dabrafenib/encorafenibCardiac dysfunction: case report
Reactions Weekly, 2024, 2024 (1) : 98 - 98
[40] Palmoplantar hyperkeratosis: a skin manifestation of juvenile dermatomyositis
Smith, V.
Clark, S.
BRITISH JOURNAL OF DERMATOLOGY, 2014, 170 (01) : E9 - E9

← 1 2 3 4 5 →